Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood

Annals of Hematology

Volumn 92, Issue 1, 2013, Pages 89-96

  Jiang, Neng Gang ^a   Jin, Yong Mei ^a   Niu, Qian ^a   Zeng, Ting Ting ^a   Su, Jun ^a   Zhu, Huan Ling ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Flow cytometry; Immunophenotype; NK cell neoplasm

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; PERFORIN;

ADOLESCENT; AGED; AGGRESSIVE NK CELL LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CANCER CYTODIAGNOSIS; CANCER STAGING; CELL STRUCTURE; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NATURAL KILLER CELL LYMPHOMA; NATURAL KILLER CELL; NATURAL KILLER CELL CHROMIC LYMPHOPROLIFERATIVE DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; BIOPSY; BLOOD CELLS; BONE MARROW; BONE MARROW EXAMINATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84872284237     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1574-3     Document Type: Article

References (27)

1. Liang X, Graham DK (2008) Natural killer cell neoplasms. Cancer 112(7):1425-1436
2. Chan JK, Sin VC, Wong KF et al (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89(12):4501-4514
3. Au WY, Ma SY, Chim CS et al (2005) Clinicopathologic features and treatment outcome of mature T-cell and naturalkiller-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 16(2):206-214
4. Kwong YL (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19(12):2186-2194
5. Ryder J, Wang X, Bao L et al (2007) Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol 85(1):18-25
6. Kwong YL, Chan AC, Liang RH (1997) Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol 15(2):71-79
7. Sokol L, Loughran TP (2006) Large granular lymphocyte leukemia. Oncologist 11(3):263-273
8. Steven HS, Elias C, Nance LH, et al. (2008) WHO classification of tumors of haematopoietic and lymphoid tissues. International agency for research on cancer. Lyon; pp: 274-288
9. Suzuki R, Suzumiya J, Nakamura S et al (2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18:763-770
10. Lima M, Almeida J, Montero AG et al (2004) Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 165(4):1117-1127
11. Kämmerer U, Kapp M, Gassel AM et al (2001) A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 49(5):623-630
12. Morice WG (2007) The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol 127(6):881-886
13. Carson WE, Fehniger TA, Caligiuri MA (1997) CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol 27(2):354-360
14. Chan A, Hong DL, Atzberger A et al (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179(1):89-94
15. Björkström NK, Riese P, Heuts F et al (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116(19):3853-3864
16. Trotta R, Parihar R, Yu J et al (2005) Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 105(8):3011-3018
17. Li YX, Fang H, Liu QF et al (2008) Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood 112(8):3057-3064
18. Kwong YL (2009) High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies. Bone Marrow Transplant 44(11):709-714
19. Lanier LL, Chang C, Azuma M et al (1991) Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol 146(12):4421-4426
20. Raspadori D, Damiani D, Lenoci M et al (2001) CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 15(8):1161-1164
21. Aloysius MM, Zaitoun AM, Awad S et al (2010) Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. Br J Surg 97(8):1269-1278
22. Liang R (2000) Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin. Clin Lymphoma 1(1):33-37
23. Todd JA, Lubomir S (2007) Diseases of large granular lymphocytes. Cancer Control 14(2):141-150
24. Lopez-Vergès S, Milush JM, Pandey S et al (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116(19):3865-3874
25. Falcão RP, Rizzatti EG, Saggioro FP et al (2007) Flow cytometry characterization of leukemic phase of nasal NK/T-cell lymphoma in tumor biopsies and peripheral blood. Haematologica 92(2):e24-e25
26. Ohshima K, Suzumiya J, Shimazaki K et al (1997) Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 31(5):444-450
27. Oshimi K (1996) Lymphoproliferative disorders of natural killer cells. Int J Hematol 63(4):279-290